https://www.thebodypro.com/category/hiv-treatments-in-development/tag/interviews

The Latest

Wakefield headshot.

This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect

Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.

By Kenyon Farrow
injectable

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
Shahin Lockman.

Whether HIV or COVID-19, Pregnant or Lactating Cisgender Women Need to Be Included in Clinical Trials for Therapies

Dr. Shahin Lockman says to not include women in trials is unethical.

By Terri Wilder, M.S.W.
Toby Pepperrell

Is Virologic Failure the Best Endpoint in Clinical Trials for Integrase Inhibitors?

Using data from the ADVANCE trial, this researcher suggests people with HIV with low-level viremia may still get to undetectable.

By Terri Wilder, M.S.W.
What You Need to Know About the Second Person Likely Cured of HIV Img

What You Need to Know About the Second Person Likely Cured of HIV

Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.

By Kenyon Farrow
Promo Image

What Major HIV Research Developments Does 2014 Hold in Store?

In a field of research as rapidly evolving as HIV, new developments come fast and furious; anticipating the research that’s most likely to make waves can be a challenge. That’s why we turn to experts for their thoughts, predictions and educated guesses.

By Warren Tong